Kobayashi Pharmaceutical Co Ltd (4967:TSE) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the Kobayashi Pharmaceutical Co Ltd stock forecast from 0 analysts, the average analyst target price for Kobayashi Pharmaceutical Co Ltd is not available over the next 12 months. Kobayashi Pharmaceutical Co Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Kobayashi Pharmaceutical Co Ltd is Slightly Bearish, which is based on 4 positive signals and 8 negative signals. At the last closing, Kobayashi Pharmaceutical Co Ltd’s stock price was JPY 5,996.00. Kobayashi Pharmaceutical Co Ltd’s stock price has changed by -0.56% over the past week, +13.24% over the past month and -9.67% over the last year.
No recent analyst target price found for Kobayashi Pharmaceutical Co Ltd
No recent average analyst rating found for Kobayashi Pharmaceutical Co Ltd
Company Overview Kobayashi Pharmaceutical Co Ltd
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. The company offers Ammeltz, a topical analgesic; Bluelet Decoral, a toilet bowl cleaner and freshener; Shoshugen, air freshener; Inochi no Haha, a women's health medicine; Eyebon, an eye wash; Sarasaty lingerie soap; Naishitol, a Chinese medicine; Eaude Muge, a medicated lotion for preventing acne; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet for forehead; Sawaday, a toilet air freshener; and deodorizing air freshener, lens cleaner, and oral hygiene products. It also manufactures and sells pharmaceuticals, quasi-drugs, cosmetics, and health foods; and processed synthetic resin products; markets nutritional supplements and skin care products through website and over the phone; and sells skincare products, daily necessities, and health foods, as well as manufactures body warmers. In addition, the company engages in transportation, real estate management, and advertising planning and production businesses; and asset management. Further, it engages in transportation, real estate management, and advertising planning and production businesses; and asset management. Additionally, the company engages in sanitary paper products related businesses. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan. Read Less
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. The company offers Ammeltz, a topical analgesic; Bluelet Decoral, a toilet bowl cleaner and freshener; Shoshugen, air freshener; Inochi no Ha...Read More
Frequently Asked Questions About Kobayashi Pharmaceutical Co Ltd (4967:TSE) Stock
Stock Target Advisor's fundamental analysis for Kobayashi Pharmaceutical Co Ltd's stock is Slightly Bearish.
4967:TSE stock's dividend yield is 2.00%.
Our analysis grades 4967:TSE stock's dividend yield at F. This means that 4967:TSE stock's dividend yield is above 39% of the stocks in the Household & Personal Products sector in the TSE exchange.
Based on this 4967:TSE may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on 4967:TSE's stock to indicate what its average analyst target is.
4967:TSE stock's Price/Earning ratio is 43.88.
Our analysis grades 4967:TSE stock's Price / Earning ratio at F. This means that 4967:TSE stock's Price/Earning ratio is above 71% of the stocks in the Household & Personal Products sector in the TSE exchange.
Based on this 4967:TSE may be a overvalued for its sector.
The last closing price of 4967:TSE's stock was JPY 5,996.00.
The most recent market capitalization for 4967:TSE is JPY 444.99B.
Unfortunately we do not have enough analyst data on 4967:TSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Kobayashi Pharmaceutical Co Ltd's stock.
As per our most recent records Kobayashi Pharmaceutical Co Ltd has 3,534 Employees.
Kobayashi Pharmaceutical Co Ltd's registered address is KDX Kobayashi Doshomachi Building, Osaka, Japan, 541-0045.
You can get more information about it from Kobayashi Pharmaceutical Co Ltd's website at https://www.kobayashi.co.jp.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Dividend Growth
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Kobayashi Pharmaceutical Co Ltd (4967:TSE) Stock
Stock Target Advisor's fundamental analysis for Kobayashi Pharmaceutical Co Ltd's stock is Slightly Bearish.
4967:TSE stock's dividend yield is 2.00%.
Our analysis grades 4967:TSE stock's dividend yield at F. This means that 4967:TSE stock's dividend yield is above 39% of the stocks in the Household & Personal Products sector in the TSE exchange.
Based on this 4967:TSE may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on 4967:TSE's stock to indicate what its average analyst target is.
4967:TSE stock's Price/Earning ratio is 43.88.
Our analysis grades 4967:TSE stock's Price / Earning ratio at F. This means that 4967:TSE stock's Price/Earning ratio is above 71% of the stocks in the Household & Personal Products sector in the TSE exchange.
Based on this 4967:TSE may be a overvalued for its sector.
The last closing price of 4967:TSE's stock was JPY 5,996.00.
The most recent market capitalization for 4967:TSE is JPY 444.99B.
Unfortunately we do not have enough analyst data on 4967:TSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Kobayashi Pharmaceutical Co Ltd's stock.
As per our most recent records Kobayashi Pharmaceutical Co Ltd has 3,534 Employees.
Kobayashi Pharmaceutical Co Ltd's registered address is KDX Kobayashi Doshomachi Building, Osaka, Japan, 541-0045.
You can get more information about it from Kobayashi Pharmaceutical Co Ltd's website at https://www.kobayashi.co.jp.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 4967:TSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
